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Introduction: Recommendations for lose-dose CT screening for lung cancer (LC) 
targets a population at concomitant risk for coronary disease. Coronary artery 
calcifications (CAC) are an independent predictor of cardiovascular events among 
screening patients, and atherosclerotic cardiovascular disease (ASCVD) was the 
leading cause of death in the National Lung Screening Trial. In this study, we tested the 
hypothesis that patients with severe CAC undergo more risk factor modification when 
seen by a cardiologist.   
Methods: A chart review assessing patients found to have severe CAC on screening 
LDCT between January 2018 and April 2019 was conducted. Patient demographics, 
medical history, and cardiology data were obtained from the electronic medical record. 
Results: Of 580 patients who underwent LC screening, forty patients (6.9%) had severe 
CAC. 70% of these patients (28/40) had ASCVD at baseline. Twenty-three patients 
(57.5%) were subsequently seen by a cardiologist. Of these patients, 12 (52.2%) were 
started on or had a dose increase in cardiac medications; 9 (39.1%) underwent stress 
testing; 12 (52.2%) had an echocardiogram; and 3 patients (13.0%) underwent coronary 
angiography. Among the 17 patients not seen by a cardiologist, 2 patients (11.8%) had 
an increase in cardiac medications, and none underwent cardiac procedures.  
Discussion: Patients with severe CAC detected on LDCT screening have a high 
incidence of known ASCVD. Those who are referred to Cardiology undergo procedures 
and medication changes at a higher rate than patients not seen by a cardiologist. Future 
directions should include examining the impact of cardiac interventions on ASCVD 
mortality in this population. 
